{"uid":"cap_3QEhfD12tY33RBoSNRcf9","slug":"clinicalintelpulse-biotech-m-a-deal-signal-lite-clinicaltrials-gov-bf8217ba","name":"ClinicalIntelPulse: Biotech M&A Deal-Signal Lite (ClinicalTrials.gov Preview)","description":"Deterministic preview of biotech M&A deal-signal candidates — Phase 2/3 trial counts and the industry-sponsored asset list straight off ClinicalTrials.gov, no LLM synthesis. For agents with small per-call budgets; upgrade to deal-signal for acquisition rationale, deal comps with dollar values, likely acquirers and timing signals.","url":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/deal-signal-lite","method":"GET","headers":{},"bodySchema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"type":{"type":"string","const":"http"},"method":{"enum":["GET","HEAD","DELETE"],"type":"string"},"queryParams":{"type":"object","properties":{"stage":{"type":"string"},"condition":{"type":"string"}}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"errors":{"type":"object","description":"Documented error responses, keyed by HTTP status code","additionalProperties":{"type":"object","required":["description"],"properties":{"example":{"type":"object"},"description":{"type":"string"}}}},"example":{"type":"object"}}}}},"responseSchema":{"type":"json","example":{"upsell":{"adds":"Acquisition rationale per asset, recent deal comps with dollar values, estimated deal-value ranges, likely acquirers, deal-timing signals.","price_usd":0.35,"full_product":"/api/clinical/deal-signal"},"deterministic":true,"query_summary":{"as_of":"2026-07-25","stage":"both","condition":"Obesity"},"pipeline_totals":{"phase2_count":62,"phase3_count":18,"total_active":80},"candidate_assets":[{"nctId":"NCT05564117","phase":"PHASE3","title":"Mazdutide in Obesity","status":"ACTIVE_NOT_RECRUITING","sponsor":"Innovent Biologics"}],"sponsor_breakdown":[{"sponsor":"Novo Nordisk A/S","trial_count":8}],"industry_sponsored":{"total":66,"phase2_count":51,"phase3_count":15}}},"example":null,"exampleRequest":null,"tags":["x402"],"displayCostAmount":"0.25","displayCostAsset":"USDC","priceDynamic":false,"priceHint":null,"priceStatus":"priced","priceSource":"probe","requiresHandshake":false,"reviewCount":0,"rating":{"score":"0.00","successRate":"0.00","reviews":0,"stars":null,"state":"unrated"},"availabilityStatus":"unknown","priceObserved":null,"sessionDeposit":null,"pricing":{"kind":"static","summary":"$0.25/call","primary":{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.25","per":"call","confidence":"exact"},"accepted":[{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.25","per":"call","confidence":"exact"}]},"paymentMethods":[{"uid":"pm_9ch3P_JYOg2Y1BaKiJEkh","protocol":"x402","methodType":"crypto","chain":"base","mode":"charge","costAmount":"0.25","costPer":"request","priority":0,"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","unit":"request","depositMicros":null,"planRef":null}],"brandName":null,"brandSlug":null,"brandBaseUrl":null,"brandDocsUrl":null,"whatItDoes":"Returns a deterministic, LLM-free preview of biotech M&A deal-signal candidates for a disease area — Phase 2/3 trial counts and industry-sponsored asset lists sourced directly from ClinicalTrials.gov.","exampleAgentPrompt":"Give me a quick deal-signal preview for oncology — I want the Phase 2/3 trial counts and the list of industry-sponsored assets from ClinicalTrials.gov so I can spot potential M&A targets before deciding whether to pull the full acquisition rationale report.","exampleUseCases":[{"title":"Oncology M&A target screening","prompt":"Pull the deal-signal lite preview for non-small cell lung cancer — show me how many Phase 2 and Phase 3 trials are running and which companies are sponsoring them, so I can spot acquisition candidates."},{"title":"Rare disease pipeline triage","prompt":"I'm looking at rare diseases for a potential acquisition — can you get me the Phase 2/3 trial counts and industry-sponsored asset list for Duchenne muscular dystrophy from ClinicalTrials.gov?"},{"title":"Therapeutic area budget scan","prompt":"Before I spend on the full deal-signal report, give me the lite preview for NASH — Phase 2 and Phase 3 counts plus the sponsor list — so I can decide if there are enough M&A candidates to justify digging deeper."}],"resultDescription":"Returns Phase 2 and Phase 3 trial counts for the queried disease area along with a list of industry-sponsored clinical assets sourced deterministically from ClinicalTrials.gov — no LLM synthesis. Does not include acquisition rationale, deal comps with dollar values, likely acquirers, or timing signals (those are in the full deal-signal endpoint).","failureModes":["Disease/indication not found or too broadly specified — returns empty or minimal results","ClinicalTrials.gov upstream data unavailable or stale — may return cached or error response","Misspelled indication name — may return zero results with no fuzzy matching","Rate limit or payment verification failure — 402 response if USDC payment not confirmed","Ambiguous disease name mapping — endpoint may return results for a broader or narrower indication than intended"],"whenToPreferThis":"Choose this endpoint when you need a fast, low-cost ($0.25 USDC) deterministic snapshot of Phase 2/3 trial activity and industry-sponsored assets for a disease area as an M&A deal-signal triage step. Prefer it over the full deal-signal endpoint when you are screening multiple indications on a budget and don't yet need acquisition rationale, deal comps, likely acquirers, or timing signals. Prefer it over generic clinical trial search endpoints when the specific goal is identifying M&A candidates by sponsor and trial phase.","instructions":null,"reviewSummary":null,"reviewSummaryHighlights":null,"reviewSummaryConcerns":null,"reviewSummaryGeneratedAt":null,"activationCount":0,"lastUsedAt":null,"lastSuccessfullyRanAt":null,"lastHealthCheckAt":"2026-09-14T12:45:42.510Z","isFirstParty":false}